The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles

References

• RyuJHKooHSunICTumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapyAdv Drug Deliv Rev201264131447145822772034
   PubMed Web of Science ®Google Scholar
• SchleichNDanhierFPréatVIron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translationJ Control Release2015198355425481448
   PubMed Web of Science ®Google Scholar
• HahnMASinghAKSharmaPBrownSCMoudgilBMNanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectivesAnal Bioanal Chem2011399132720924568
   PubMed Web of Science ®Google Scholar
• BennettKMJoJCabralHBakalovaRAokiIMR imaging techniques for nano-pathophysiology and theranosticsAdv Drug Deliv Rev201474759424787226
   PubMed Web of Science ®Google Scholar
• Roy ChowdhuryMSchumannCBhakta-GuhaDGuhaGCancer nanotheranostics: strategies, promises and impedimentsBiomed Pharmacother20168429130427665475
   PubMed Web of Science ®Google Scholar
• SchleichNDanhierFPréatVIron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translationJ Control Release2015198355425481448
   PubMed Web of Science ®Google Scholar
• GobboOLSjaastadKRadomskiMWVolkovYPrina-MelloAMagnetic nanoparticles in cancer theranosticsTheranostics20155111249126326379790
   PubMed Web of Science ®Google Scholar
• KandasamyGMaityDRecent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranosticsInt J Pharm2015496219121826520409
   PubMed Web of Science ®Google Scholar
• MahmoudiMSantSWangBLaurentSSenTSuperparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapyAdv Drug Deliv Rev2011631–2244620685224
   PubMed Web of Science ®Google Scholar
• ZhouHQianWUckunFMIGF1 receptor targeted theranostic nanoparticles for targeted and image-guided therapy of pancreatic cancerACS Nano2015987976799126242412
   PubMed Web of Science ®Google Scholar
• ZarrinASadighianSRostamizadehKDesign, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapyInt J Pharm20165001–2627626721723
   PubMedGoogle Scholar
• WangDFeiBHaligLVTargeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancerACS Nano2014876620663224923902
   PubMed Web of Science ®Google Scholar
• XingHHwangKLuYRecent developments of liposomes as nanocarriers for theranostic applicationsTheranostics2016691336135227375783
   PubMed Web of Science ®Google Scholar
• ClaresBBiedma-OrtizRASáez-FernándezENano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancerEur J Pharm Biopharm2013853 Pt A32933823485475
   PubMed Web of Science ®Google Scholar
• ChenYChenYXiaoDBoseADengRBothunGDLow-dose chemotherapy of hepatocellular carcinoma through triggered-release from bilayer-decorated magnetoliposomesColloids Surf B Biointerfaces201411645245824549047
   PubMed Web of Science ®Google Scholar
• Di CoratoRBéalleGKolosnjaj-TabiJCombining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomesACS Nano2015932904291625695371
   PubMed Web of Science ®Google Scholar
• GuoHChenWSunXLiuYNLiJWangJTheranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic fieldCarbohydr Polym201511820921725542126
   PubMed Web of Science ®Google Scholar
• ZhangLZhouHBelzileOThorpePZhaoDPhosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in miceJ Control Release201418311412324698945
   PubMed Web of Science ®Google Scholar
• TianYZhangYTengZpH-Dependent transmembrane activity of peptide-functionalized gold nanostars for computed tomography/photoacoustic imaging and photothermal therapyACS Appl Mater Interfaces2017932114212228058834
   PubMed Web of Science ®Google Scholar
• FarkhaniSMValizadehAKaramiHMohammadiSSohrabiNBadrzadehFCell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic moleculesPeptides201457789424795041
   PubMed Web of Science ®Google Scholar
• ShiKLiJCaoZA pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanomaJ Control Release201521713815026368312
   PubMed Web of Science ®Google Scholar
• SchachDKRockWFranzJBonnMParekhSHWeidnerTReversible activation of a cell-penetrating peptide in a membrane environmentJ Am Chem Soc201513738121991220226335659
   PubMed Web of Science ®Google Scholar
• ZhaoBXZhaoYHuangYThe efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxelBiomaterials20123382508252022197569
   PubMed Web of Science ®Google Scholar
• ZhaoYRenWZhongTTumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activityJ Control Release2016222566626682502
   PubMed Web of Science ®Google Scholar
• RenWZhangSZhongTThe preparation and characteristics of sterically stabilized liposomes containing paclitaxel and super-paramagnetic iron oxide nanoparticlesJ Chin Pharm Sci2016258570575
   Google Scholar
• LuoLMHuangYZhaoBXAnti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelBiomaterials20133441102111423127332
   PubMed Web of Science ®Google Scholar
• LiuXRWuKCHuangYIn vitro and in vivo studies on plasma-to-blood ratio of paclitaxel in human, rabbit and rat blood fractionsBiol Pharm Bull20083161215122018520057
   PubMed Web of Science ®Google Scholar
• HuangDZhangSZhongTMulti-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapyOncotarget2016728436164362827283987
   PubMedGoogle Scholar
• SongPYaoXZhongTThe anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrugOncotarget2016730484674848027366947
   PubMedGoogle Scholar
• ZhongTYaoXZhangSA self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristicSci Rep201663661427812039
   PubMed Web of Science ®Google Scholar
• GuoYZhongTDuanXCImproving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrixDrug Deliv201724127027728165798
   PubMed Web of Science ®Google Scholar
• RamzyLNasrMMetwallyAAAwadGASCancer nanotheranostics: a review of the role of conjugated ligands for overexpressed receptorsEur J Pharm Sci201710427329228412485
   PubMed Web of Science ®Google Scholar
• ZongYWuJShenKNanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysisOncotarget2017810173601737228061451
   PubMedGoogle Scholar
• DaiZYueXLiposomal nanotechnology for cancer theranosticsCurr Med Chem Epub201735
   Web of Science ®Google Scholar
• SeleciMAg SeleciDScheperTStahlFTheranostic liposome-nanoparticle hybrids for drug delivery and bioimagingInt J Mol Sci2017187E141528671589
   PubMed Web of Science ®Google Scholar
• ChenQShangWZengCTheranostic imaging of liver cancer using targeted optical/MRI dual-modal probesOncotarget2017820327413275128416757
   PubMedGoogle Scholar